| The proto-oncogene Bcl3, induced by Tax, represses Tax-mediated transcription via p300 displacement from the human T-cell leukemia virus type 1 promoter. | leukemia, |
| The role of the Bcl-3 proto-oncogene in thyroid hormone-induced liver cell proliferation. | liver,thyroid, |
| Activation of the PI3K-Akt pathway by human T cell leukemia virus type 1 (HTLV-1) oncoprotein Tax increases Bcl3 expression, which is associated with enhanced growth of HTLV-1-infected T cells. | leukemia, |
| Expression of Id proteins is regulated by the Bcl-3 proto-oncogene in prostate cancer. | prostate, |
| BCL3 serves as an oncogene in glioma by modulating proliferation, cell cycle progression and apoptosis, and its oncogenic effects are mediated by the STAT3 signaling pathway. | glioma, |
| The candidate oncoprotein Bcl-3 is an antagonist of p50/NF-kappa B-mediated inhibition. | None |
| The proto-oncogene bcl-3 encodes an I kappa B protein. | None |
| Candidate proto-oncogene bcl-3 encodes a subunit-specific inhibitor of transcription factor NF-kappa B. | None |
| Bcl-3 might participate in oncogenic pathways involving Lck | None |
| Expression of the Bcl-3 proto-oncogene suppresses p53 activation. | None |
| The latent membrane protein 1 (LMP1) encoded by Epstein-Barr virus induces expression of the putative oncogene Bcl-3 through activation of the nuclear factor-kappaB. | None |
| The repressing function of the oncoprotein BCL-3 requires CtBP, while its polyubiquitination and degradation involve the E3 ligase TBLR1. | None |
| Data defined a unique motif of BCL-3 that is needed for its recruitment to the proteasome and identified PSMB1 as a key protein required for the proteasome-mediated degradation of a nuclear and oncogenic IkappaB protein. | None |
| inhibitory effect on OC cell growth was mediated by miR-125b inhibition of the translation of an mRNA encoding a proto-oncogene, BCL3 | None |
| Depletion of the oncoprotein Bcl-3 induces centrosome amplification and aneuploidy in cancer cells. | None |
| The candidate proto-oncogene bcl-3 is related to genes implicated in cell lineage determination and cell cycle control. | None |
| The oncoprotein and transcriptional regulator Bcl-3 governs plasticity and pathogenicity of autoimmune T cells. | None |
| An integrated genomic-transcriptomic approach supports a role for the proto-oncogene BCL3 in atherosclerosis. | None |
| Genomic structure of the candidate proto-oncogene BCL3. | None |
| The candidate proto-oncogene bcl-3 encodes a transcriptional coactivator that activates through NF-kappa B p50 homodimers. | None |